Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
申请人:Pfizer Inc.
公开号:US06531492B1
公开(公告)日:2003-03-11
The present invention relates to compounds of the formula
wherein R2, R3, R6 and A are defined as in the specification, to pharmaceutical compositions containing them and to their medicinal use. The compounds of the invention are useful in the treatment or alleviation of inflammation and other inflammation associated disorders, such as osteoarthritis, rheumatoid arthritis, colon cancer and Alzheimer's disease, in mammals (preferably humans, dogs, cats and livestock).
本发明涉及公式中R2、R3、R6和A如规范中定义的化合物,以及含有它们的药物组合物和它们的药用。本发明的化合物在治疗或缓解炎症和其他与炎症有关的疾病中有用,如骨关节炎、类风湿性关节炎、结肠癌和阿尔茨海默病,在哺乳动物(最好是人类、狗、猫和家畜)中。